Compare VICR & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VICR | MEDP |
|---|---|---|
| Founded | 1981 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.1B | 15.4B |
| IPO Year | 1995 | 2016 |
| Metric | VICR | MEDP |
|---|---|---|
| Price | $220.83 | $603.89 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 12 |
| Target Price | $217.50 | ★ $473.17 |
| AVG Volume (30 Days) | ★ 817.4K | 346.7K |
| Earning Date | 04-21-2026 | 04-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1764.29 | 20.98 |
| EPS | 0.44 | ★ 8.53 |
| Revenue | ★ $452,701,000.00 | N/A |
| Revenue This Year | $37.01 | $13.19 |
| Revenue Next Year | $39.47 | $7.75 |
| P/E Ratio | $479.27 | ★ $70.98 |
| Revenue Growth | ★ 26.08 | N/A |
| 52 Week Low | $45.44 | $373.00 |
| 52 Week High | $382.65 | $677.90 |
| Indicator | VICR | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 46.48 | 64.86 |
| Support Level | $134.89 | $577.01 |
| Resistance Level | $232.35 | $609.13 |
| Average True Range (ATR) | 15.55 | 16.05 |
| MACD | 4.03 | -0.04 |
| Stochastic Oscillator | 78.86 | 75.15 |
Vicor Corp manufactures and markets modular power components and complete power systems for converting electrical power. It provides modular power converters and configurable products, power component products and integrated circuits, and related products. Its products include Converters, Power Systems, Filters, Custom Power Systems, Input Modules, and others. The principal markets for the Company's power converters and systems are large original equipment manufacturers (OEMs), original design manufacturers (ODMs) and their contract manufacturers, and smaller, lower volume users, which are broadly distributed across several market areas.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.